Kestra Medical Technologies, Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KMTS research report →
Companykestramedical.com
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
- CEO
- Brian Webster
- IPO
- 2025
- Employees
- 300
- HQ
- Kirkland, WA, US
Price Chart
Valuation
- Market Cap
- $1.21B
- P/E
- -7.57
- P/S
- 14.47
- P/B
- 3.81
- EV/EBITDA
- -7.22
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 48.75%
- Op Margin
- -171.53%
- Net Margin
- -172.99%
- ROE
- -68.83%
- ROIC
- -42.69%
Growth & Income
- Revenue
- $59.81M · 115.05%
- Net Income
- $-113,814,000 · -20.92%
- EPS
- $-5.13 · -151.47%
- Op Income
- $-106,378,000
- FCF YoY
- -19.41%
Performance & Tape
- 52W High
- $30.00
- 52W Low
- $13.25
- 50D MA
- $20.57
- 200D MA
- $22.86
- Beta
- 0.83
- Avg Volume
- 357.52K
Get TickerSpark's AI analysis on KMTS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Webster Brian Daniel | sell | 8,155 |
| May 15, 26 | Webster Brian Daniel | sell | 6,845 |
| Apr 15, 26 | Webster Brian Daniel | sell | 15,000 |
| Mar 26, 26 | COHEN RAYMOND W | buy | 10,000 |
| Mar 17, 26 | Webster Brian Daniel | sell | 15,000 |
| Mar 11, 26 | Reilly Kevin C | other | 8,300 |
| Feb 17, 26 | Webster Brian Daniel | sell | 11,635 |
| Feb 17, 26 | Webster Brian Daniel | sell | 3,272 |
| Feb 17, 26 | Webster Brian Daniel | sell | 93 |
| Jan 15, 26 | Webster Brian Daniel | sell | 15,000 |
Our KMTS Coverage
We haven't published any research on KMTS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KMTS Report →